For help on how to get the results you want, see our search tips.
1721 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Opinions on medicines for use outside EU Remove Opinions on medicines for use outside EU filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Comirnaty (updated)
Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2, COVID-19 virus infection
Date of authorisation: 21/12/2020,
, 
, Revision: 40, Authorised, Last updated: 15/03/2023
-
List item
Human medicine European public assessment report (EPAR): NeoRecormon (updated)
epoetin beta, Kidney Failure, Chronic; Anemia; Cancer; Blood Transfusion, Autologous
Date of authorisation: 16/07/1997, Revision: 33, Authorised, Last updated: 15/03/2023 -
List item
Human medicine European public assessment report (EPAR): Zinplava (updated)
bezlotoxumab, Enterocolitis, Pseudomembranous
Date of authorisation: 18/01/2017, Revision: 9, Authorised, Last updated: 14/03/2023 -
List item
Human medicine European public assessment report (EPAR): Drovelis (updated)
drospirenone, estetrol monohydrate, Contraceptives, Oral
Date of authorisation: 19/05/2021, Revision: 3, Authorised, Last updated: 14/03/2023 -
List item
Human medicine European public assessment report (EPAR): Ayvakyt (updated)
avapritinib, Gastrointestinal Stromal Tumors
Date of authorisation: 24/09/2020,, 
, 
, Revision: 6, Authorised, Last updated: 14/03/2023
-
List item
Human medicine European public assessment report (EPAR): Cablivi (updated)
Caplacizumab, Purpura, Thrombotic Thrombocytopenic
Date of authorisation: 30/08/2018,, , Revision: 7, Authorised, Last updated: 14/03/2023
-
List item
Human medicine European public assessment report (EPAR): Invirase (updated)
saquinavir, HIV Infections
Date of authorisation: 03/10/1996, Revision: 50, Authorised, Last updated: 13/03/2023 -
List item
Human medicine European public assessment report (EPAR): Ivozall (updated)
clofarabine, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation: 14/11/2019,
, Revision: 4, Authorised, Last updated: 13/03/2023
-
List item
Human medicine European public assessment report (EPAR): Adcetris (updated)
Brentuximab vedotin, Lymphoma, Non-Hodgkin; Hodgkin Disease
Date of authorisation: 25/10/2012,, Revision: 34, Authorised, Last updated: 13/03/2023
-
List item
Human medicine European public assessment report (EPAR): Nityr (updated)
nitisinone, Tyrosinemias
Date of authorisation: 26/07/2018,, Revision: 4, Authorised, Last updated: 10/03/2023
-
List item
Human medicine European public assessment report (EPAR): Ebvallo (updated)
Tabelecleucel, Lymphoproliferative Disorders
Date of authorisation: 16/12/2022,, , 
, Revision: 2, Authorised, Last updated: 10/03/2023
-
List item
Human medicine European public assessment report (EPAR): Ronapreve (updated)
casirivimab, imdevimab, COVID-19 virus infection
Date of authorisation: 12/11/2021,, Revision: 3, Authorised, Last updated: 10/03/2023
-
List item
Human medicine European public assessment report (EPAR): Cosentyx (updated)
Secukinumab, Arthritis, Psoriatic; Psoriasis; Spondylitis, Ankylosing
Date of authorisation: 14/01/2015, Revision: 30, Authorised, Last updated: 09/03/2023 -
List item
Human medicine European public assessment report (EPAR): Caprelsa (updated)
Vandetanib, Thyroid Neoplasms
Date of authorisation: 16/02/2012,, Revision: 24, Authorised, Last updated: 09/03/2023
-
List item
Human medicine European public assessment report (EPAR): Hukyndra (updated)
adalimumab, Arthritis, Psoriatic; Arthritis, Juvenile Rheumatoid; Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Hidradenitis Suppurativa; Psoriasis; Spondylitis, Ankylosing; Uveitis
Date of authorisation: 15/11/2021,
, Revision: 4, Authorised, Last updated: 09/03/2023
-
List item
Human medicine European public assessment report (EPAR): Leflunomide medac (updated)
leflunomide, Arthritis, Rheumatoid
Date of authorisation: 27/07/2010,, Revision: 18, Authorised, Last updated: 09/03/2023
-
List item
Human medicine European public assessment report (EPAR): Circadin (updated)
melatonin, Sleep Initiation and Maintenance Disorders
Date of authorisation: 29/06/2007, Revision: 33, Authorised, Last updated: 09/03/2023 -
List item
Human medicine European public assessment report (EPAR): Omidria (updated)
ketorolac, phenylephrine, Lens Implantation, Intraocular; Pain, Postoperative
Date of authorisation: 28/07/2015, Revision: 7, Authorised, Last updated: 09/03/2023 -
List item
Human medicine European public assessment report (EPAR): Olanzapine Apotex (updated)
olanzapine, Schizophrenia; Bipolar Disorder
Date of authorisation: 10/06/2010,, Revision: 13, Authorised, Last updated: 09/03/2023
-
List item
Human medicine European public assessment report (EPAR): Rizmoic (updated)
Naldemedine tosilate, Constipation
Date of authorisation: 18/02/2019,, Revision: 8, Authorised, Last updated: 09/03/2023
-
List item
Human medicine European public assessment report (EPAR): Rivaroxaban Mylan (updated)
rivaroxaban, Venous Thromboembolism; Pulmonary Embolism; Acute Coronary Syndrome; Stroke; Coronary Artery Disease; Peripheral Arterial Disease; Atrial Fibrillation
Date of authorisation: 12/11/2021,, Revision: 1, Authorised, Last updated: 09/03/2023
-
List item
Human medicine European public assessment report (EPAR): Arava (updated)
leflunomide, Arthritis, Rheumatoid; Arthritis, Psoriatic
Date of authorisation: 02/09/1999, Revision: 40, Authorised, Last updated: 09/03/2023 -
List item
Human medicine European public assessment report (EPAR): Vimpat (updated)
lacosamide, Epilepsy
Date of authorisation: 29/08/2008, Revision: 44, Authorised, Last updated: 08/03/2023 -
List item
Human medicine European public assessment report (EPAR): Stivarga (updated)
regorafenib, Colorectal Neoplasms
Date of authorisation: 26/08/2013, Revision: 20, Authorised, Last updated: 08/03/2023 -
List item
Human medicine European public assessment report (EPAR): Briviact (in Italy: Nubriveo) (updated)
Brivaracetam, Epilepsy
Date of authorisation: 13/01/2016, Revision: 19, Authorised, Last updated: 08/03/2023